Close ☰
Menu ☰

News

27th November, 2015

A new diet provides hope for treating patients with drug resistant epilepsy

Scientists from Royal Holloway, University of London and UCL have identified how a specific diet can be used to help treat patients with uncontrolled epilepsy.

The findings, which reveal how the ketogenic diet acts to block seizures in patients with drug-resistant epilepsy, are published today (25 November) in the journal Brain.

Epilepsy affects over 50 million people worldwide and approximately a third of people diagnosed with epilepsy do not have seizures adequately controlled by current treatments.

The research team have identified a specific fatty acid, decanoic acid, provided in the MCT (medium chain triglyceride, a chemical containing three fatty acids) ketogenic diet that has potent anti-epileptic effects. The diet comprises of high levels of fat and low levels of carbohydrate-containing foods.

To read more, click here


Refine Results

  • Select date range (from/to)

Other Recent News

NCCPE

Includes the launch of a special collection of papers on #KnowledgeExchange, drawn from a 2019/2 KE and the creative industries seminar series, with an intro and reflective commentary by @Emma_Cole1: scienceopen.com/hosted-docume… (3/4)

in association with